ACT Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.06M | Sell |
58,300
-700
| -1% | -$48.8K | 5.61% | 4 |
|
|
2022
Q2 | $3.87M | Hold |
59,000
| – | – | 5.42% | 5 |
|
|
2022
Q1 | $3.93M | Hold |
59,000
| – | – | 4.15% | 6 |
|
|
2021
Q4 | $4.13M | Buy |
59,000
+19,000
| +48% | +$1.33M | 2.98% | 6 |
|
|
2021
Q3 | $2.09M | Buy |
40,000
+20,925
| +110% | +$1.09M | 1.08% | 18 |
|
|
2021
Q2 | $1.3M | Buy |
+19,075
| New | +$1.3M | 0.67% | 33 |
|